Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary Bypass
- 31 December 1987
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 44 (6), 640-645
- https://doi.org/10.1016/s0003-4975(10)62153-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.Journal of Clinical Investigation, 1986
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986
- Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.Proceedings of the National Academy of Sciences, 1986
- Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.Journal of Clinical Investigation, 1986
- Hematological Advantage of a Membrane Oxygenator over a Bubble Oxygenator in Long PerfusionsThe Annals of Thoracic Surgery, 1986
- Enhanced fibrinolytic activity during cardiopulmonary bypass in open‐heart surgery in man is caused by extrinsic (tissue‐type) plasminogen activatorEuropean Journal of Clinical Investigation, 1984
- Monitoring of aprotinin plasma levels by an enzyme-linked immunosorbent assay (ELISA)Analytical and Bioanalytical Chemistry, 1984
- A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.Journal of Clinical Investigation, 1981
- Arachidonic acid induced degranulation of rabbit peritoneal neutrophilsBiochemical and Biophysical Research Communications, 1979
- The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.Journal of Clinical Investigation, 1978